Myeloid-derived suppressor cells coming of age

[1]  B. Edil,et al.  Cancer-promoting mechanisms of tumor-associated neutrophils. , 2017, American journal of surgery.

[2]  Sijia He,et al.  Myeloid-Derived Suppressor Cells Associated With Disease Progression in Primary HIV Infection: PD-L1 Blockade Attenuates Inhibition , 2017, Journal of acquired immune deficiency syndromes.

[3]  R. Price,et al.  Effects of Obesity on the Regulation of Macrophage Population in the Prostate Tumor Microenvironment , 2017, Nutrition and cancer.

[4]  N. Harashima,et al.  Contrasting effects of cyclophosphamide on anti‐CTL‐associated protein 4 blockade therapy in two mouse tumor models , 2017, Cancer science.

[5]  K. Tarte,et al.  Early Expansion of Circulating Granulocytic Myeloid‐derived Suppressor Cells Predicts Development of Nosocomial Infections in Patients with Sepsis , 2017, American journal of respiratory and critical care medicine.

[6]  Priya Bhardwaj,et al.  Obesity alters the lung myeloid cell landscape to enhance breast cancer metastasis through IL5 and GM-CSF , 2017, Nature Cell Biology.

[7]  C. Apovian,et al.  Macrophage functions in lean and obese adipose tissue. , 2017, Metabolism: clinical and experimental.

[8]  J. Barquinero,et al.  Myeloid‐derived suppressor cells can be efficiently generated from human hematopoietic progenitors and peripheral blood monocytes , 2017, Immunology and cell biology.

[9]  James A. Hutchinson,et al.  Novel GM-CSF signals via IFN-γR/IRF-1 and AKT/mTOR license monocytes for suppressor function. , 2017, Blood advances.

[10]  C. Poets,et al.  Granulocytic myeloid‐derived suppressor cells from human cord blood modulate T‐helper cell response towards an anti‐inflammatory phenotype , 2017, Immunology.

[11]  M. Atkins,et al.  Immune Correlates of GM-CSF and Melanoma Peptide Vaccination in a Randomized Trial for the Adjuvant Therapy of Resected High-Risk Melanoma (E4697) , 2017, Clinical Cancer Research.

[12]  C. Van Waes,et al.  Anti-PD-L1 Efficacy Can Be Enhanced by Inhibition of Myeloid-Derived Suppressor Cells with a Selective Inhibitor of PI3Kδ/γ. , 2017, Cancer research.

[13]  Austin Miller,et al.  The Granulocyte Progenitor Stage Is a Key Target of IRF8-Mediated Regulation of Myeloid-Derived Suppressor Cell Production , 2017, The Journal of Immunology.

[14]  C. Poets,et al.  Neonatal myeloid derived suppressor cells show reduced apoptosis and immunosuppressive activity upon infection with Escherichia coli , 2017, European journal of immunology.

[15]  D. Viemann,et al.  S100-alarmin-induced innate immune programming protects newborn infants from sepsis , 2017, Nature Immunology.

[16]  P. Sinha,et al.  Frontline Science: Myeloid‐derived suppressor cells (MDSCs) facilitate maternal–fetal tolerance in mice , 2017, Journal of leukocyte biology.

[17]  C. Agrati,et al.  Granulocytic Myeloid–Derived Suppressor Cells Increased in Early Phases of Primary HIV Infection Depending on TRAIL Plasma Level , 2017, Journal of acquired immune deficiency syndromes.

[18]  M. Nouri,et al.  Immune regulatory network in successful pregnancy and reproductive failures. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[19]  H. Zhang,et al.  CXCL2/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer , 2017, Oncogene.

[20]  D. Gabrilovich,et al.  Dendritic cells in cancer: the role revisited. , 2017, Current opinion in immunology.

[21]  Yan Zhang,et al.  Accumulation of myeloid-derived suppressor cells (MDSCs) induced by low levels of IL-6 correlates with poor prognosis in bladder cancer , 2017, Oncotarget.

[22]  E. Zoratti,et al.  Mature CD10+ and immature CD10- neutrophils present in G-CSF-treated donors display opposite effects on T cells. , 2017, Blood.

[23]  K. Papadakis,et al.  Aberrant function of myeloid-derived suppressor cells (MDSCs) in experimental colitis and in inflammatory bowel disease (IBD) immune responses , 2017, Autoimmunity.

[24]  D. Viemann,et al.  In neonates S100A8/S100A9 alarmins prevent the expansion of a specific inflammatory monocyte population promoting septic shock , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  Q. Xiao,et al.  Neutrophil count is associated with myeloid derived suppressor cell level and presents prognostic value for hepatocellular carcinoma patients , 2017, Oncotarget.

[26]  R. Kiessling,et al.  Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma , 2017, Oncotarget.

[27]  R. DePinho,et al.  Effective Combinatorial Immunotherapy for Castration Resistant Prostate Cancer , 2017, Nature.

[28]  S. Singhal,et al.  Mouse versus Human Neutrophils in Cancer: A Major Knowledge Gap. , 2017, Trends in cancer.

[29]  J. Niu,et al.  Hepatitis C Virus Induces MDSCs-Like Monocytes through TLR2/PI3K/AKT/STAT3 Signaling , 2017, PloS one.

[30]  P. Lowenstein,et al.  Immunosuppressive Myeloid Cells' Blockade in the Glioma Microenvironment Enhances the Efficacy of Immune-Stimulatory Gene Therapy. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[31]  George A. Dominguez,et al.  Selective Targeting of Myeloid-Derived Suppressor Cells in Cancer Patients Using DS-8273a, an Agonistic TRAIL-R2 Antibody , 2016, Clinical Cancer Research.

[32]  J. Utikal,et al.  The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression , 2016, Vaccines.

[33]  Li Liu,et al.  The Role of Myeloid-Derived Suppressor Cells in Patients with Solid Tumors: A Meta-Analysis , 2016, PloS one.

[34]  D. Hartl,et al.  Differential Regulation of Myeloid-Derived Suppressor Cells by Candida Species , 2016, Front. Microbiol..

[35]  S. Bicciato,et al.  T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells. , 2016, Cancer cell.

[36]  S. Bicciato,et al.  T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells. , 2016, Cancer cell.

[37]  T. Pan,et al.  Myeloid‐derived suppressor cells are essential for maintaining feto‐maternal immunotolerance via STAT3 signaling in mice , 2016, Journal of leukocyte biology.

[38]  George A. Dominguez,et al.  Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients , 2016, Science Immunology.

[39]  Jianhong Yang,et al.  Identification of CD4+CD25+CD127- regulatory T cells and CD14+HLA-DR-/low myeloid-derived suppressor cells and their roles in the prognosis of breast cancer. , 2016, Biomedical reports.

[40]  C. Garlanda,et al.  Occurrence and significance of tumor‐associated neutrophils in patients with colorectal cancer , 2016, International journal of cancer.

[41]  Peter J. Murray,et al.  Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards , 2016, Nature Communications.

[42]  A. Zhao,et al.  CXCR2-Mediated Granulocytic Myeloid-Derived Suppressor Cells' Functional Characterization and Their Role in Maternal Fetal Interface. , 2016, DNA and cell biology.

[43]  A. Zhao,et al.  Granulocytic myeloid-derived suppressor cells maintain feto-maternal tolerance by inducing Foxp3 expression in CD4+CD25-T cells by activation of the TGF-β/β-catenin pathway. , 2016, Molecular human reproduction.

[44]  Randal J. Kaufman,et al.  The unfolded protein response in immunity and inflammation , 2016, Nature Reviews Immunology.

[45]  Tae Woo Kim,et al.  Circulating immune cell phenotype can predict the outcome of lenalidomide plus low-dose dexamethasone treatment in patients with refractory/relapsed multiple myeloma , 2016, Cancer Immunology, Immunotherapy.

[46]  J. Moorman,et al.  Expansion of myeloid-derived suppressor cells promotes differentiation of regulatory T cells in HIV-1+ individuals , 2016, AIDS.

[47]  M. Sade-Feldman,et al.  Clinical Significance of Circulating CD33+CD11b+HLA-DR− Myeloid Cells in Patients with Stage IV Melanoma Treated with Ipilimumab , 2016, Clinical Cancer Research.

[48]  Min-jung Park,et al.  Myeloid‐Derived Suppressor Cells Induce the Expansion of Regulatory B Cells and Ameliorate Autoimmunity in the Sanroque Mouse Model of Systemic Lupus Erythematosus , 2016, Arthritis & rheumatology.

[49]  S. Häusler,et al.  CD33+/HLA‐DRneg and CD33+/HLA‐DR+/− Cells: Rare Populations in the Human Decidua with Characteristics of MDSC , 2016, American journal of reproductive immunology.

[50]  N. Hiraoka,et al.  Pretreatment Immune Status Correlates with Progression-Free Survival in Chemotherapy-Treated Metastatic Colorectal Cancer Patients , 2016, Cancer Immunology Research.

[51]  R. Xavier,et al.  Trained immunity: A program of innate immune memory in health and disease , 2016, Science.

[52]  F. Necchi,et al.  Bactericidal Immunity to Salmonella in Africans and Mechanisms Causing Its Failure in HIV Infection , 2016, PLoS neglected tropical diseases.

[53]  A. Peschel,et al.  Myeloid-Derived Suppressor Cells in Bacterial Infections , 2016, Front. Cell. Infect. Microbiol..

[54]  G. Malerba,et al.  Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients , 2016, Oncotarget.

[55]  Zhong-Gao Xu,et al.  Arginase-1–dependent promotion of TH17 differentiation and disease progression by MDSCs in systemic lupus erythematosus , 2016, Science Translational Medicine.

[56]  S. Groshen,et al.  Circulating Myeloid-Derived Suppressor Cells Predict Differentiated Thyroid Cancer Diagnosis and Extent. , 2016, Thyroid : official journal of the American Thyroid Association.

[57]  R. Stienstra,et al.  Adipose tissue macrophages: going off track during obesity , 2016, Diabetologia.

[58]  Z. Cai,et al.  17β‐Oestradiol enhances the expansion and activation of myeloid‐derived suppressor cells via signal transducer and activator of transcription (STAT)−3 signalling in human pregnancy , 2016, Clinical and experimental immunology.

[59]  G. Rabinovich,et al.  Satb1 Overexpression Drives Tumor-Promoting Activities in Cancer-Associated Dendritic Cells. , 2016, Cell reports.

[60]  N. Hockstein,et al.  CD45 Phosphatase Inhibits STAT3 Transcription Factor Activity in Myeloid Cells and Promotes Tumor-Associated Macrophage Differentiation. , 2016, Immunity.

[61]  M. Schell,et al.  Phase I/II Study of Metastatic Melanoma Patients Treated with Nivolumab Who Had Progressed after Ipilimumab , 2016, Cancer Immunology Research.

[62]  Guosheng Feng,et al.  The clinical and prognostic significance of CD14+HLA-DR−/low myeloid-derived suppressor cells in hepatocellular carcinoma patients receiving radiotherapy , 2016, Tumor Biology.

[63]  H. Rosen,et al.  Hepatitis C Virus–Induced Myeloid-Derived Suppressor Cells Suppress NK Cell IFN-γ Production by Altering Cellular Metabolism via Arginase-1 , 2016, The Journal of Immunology.

[64]  D. Schadendorf,et al.  Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab , 2016, Clinical Cancer Research.

[65]  S. H. van der Burg,et al.  Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study , 2016, Cancer Immunology, Immunotherapy.

[66]  J. Fernández-Irigoyen,et al.  Drafting the proteome landscape of myeloid‐derived suppressor cells , 2016, Proteomics.

[67]  E. Morii,et al.  The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer , 2015, Scientific Reports.

[68]  D. Gabrilovich,et al.  Transcriptional regulation of myeloid‐derived suppressor cells , 2015, Journal of leukocyte biology.

[69]  C. Montesano,et al.  In HIV-positive patients, myeloid-derived suppressor cells induce T-cell anergy by suppressing CD3&zgr; expression through ELF-1 inhibition , 2015, AIDS.

[70]  L. Del Valle,et al.  Inhibition of fatty acid oxidation modulates immunosuppressive functions of myeloid-derived suppressor cells and enhances cancer therapies , 2015, Journal of Immunotherapy for Cancer.

[71]  Zhiping Wang,et al.  Prognostic significance of peripheral monocytic myeloid-derived suppressor cells and monocytes in patients newly diagnosed with diffuse large b-cell lymphoma. , 2015, International journal of clinical and experimental medicine.

[72]  M. Glymenaki,et al.  Elimination of Granulocytic Myeloid‐Derived Suppressor Cells in Lupus‐Prone Mice Linked to Reactive Oxygen Species–Dependent Extracellular Trap Formation , 2015, Arthritis & rheumatology.

[73]  D. Gabrilovich,et al.  Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected. , 2015, The Journal of clinical investigation.

[74]  S. Knapp,et al.  A core of kinase-regulated interactomes defines the neoplastic MDSC lineage , 2015, Oncotarget.

[75]  J. Becker,et al.  Impaired gp100-Specific CD8+ T-Cell Responses in the Presence of Myeloid-Derived Suppressor Cells in a Spontaneous Mouse Melanoma Model , 2015, The Journal of investigative dermatology.

[76]  Juan R. Cubillos-Ruiz,et al.  ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis , 2015, Cell.

[77]  B. Kong,et al.  Human trophoblast cells induced MDSCs from peripheral blood CD14+ myelomonocytic cells via elevated levels of CCL2 , 2015, Cellular and Molecular Immunology.

[78]  Kiran Singh,et al.  Reduced Myeloid‐derived Suppressor Cells in the Blood and Endometrium is Associated with Early Miscarriage , 2015, American journal of reproductive immunology.

[79]  W. Zou,et al.  Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies , 2015, Cancer Immunology Research.

[80]  T. Ratliff,et al.  Expression of Cationic Amino Acid Transporter 2 Is Required for Myeloid-Derived Suppressor Cell–Mediated Control of T Cell Immunity , 2015, The Journal of Immunology.

[81]  R. Schüle,et al.  Pathogenic Fungi Regulate Immunity by Inducing Neutrophilic Myeloid-Derived Suppressor Cells , 2015, Cell host & microbe.

[82]  N. Yang,et al.  Myeloid-derived suppressor cells are proinflammatory and regulate collagen-induced arthritis through manipulating Th17 cell differentiation. , 2015, Clinical immunology.

[83]  M. de Ridder,et al.  Ex vivo generation of myeloid-derived suppressor cells that model the tumor immunosuppressive environment in colorectal cancer , 2015, Oncotarget.

[84]  C. Vetro,et al.  Circulating myeloid‐derived suppressor cells correlate with clinical outcome in Hodgkin Lymphoma patients treated up‐front with a risk‐adapted strategy , 2015, British journal of haematology.

[85]  Y. Bao,et al.  Increased monocytic CD14⁺HLADRlow/- myeloid-derived suppressor cells in obesity. , 2015, Molecular medicine reports.

[86]  Dirk Roos,et al.  Neutrophils: Between Host Defence, Immune Modulation, and Tissue Injury , 2015, PLoS pathogens.

[87]  Yiping Wang,et al.  Tumor-induced CD14+HLA-DR−/low myeloid-derived suppressor cells correlate with tumor progression and outcome of therapy in multiple myeloma patients , 2015, Cancer Immunology, Immunotherapy.

[88]  A. Beineke,et al.  A Major Role for Myeloid-Derived Suppressor Cells and a Minor Role for Regulatory T Cells in Immunosuppression during Staphylococcus aureus Infection , 2015, The Journal of Immunology.

[89]  E. Passegué,et al.  Invasive breast cancer reprograms early myeloid differentiation in the bone marrow to generate immunosuppressive neutrophils , 2015, Proceedings of the National Academy of Sciences.

[90]  D. Green,et al.  Myeloid-derived suppressor activity is mediated by monocytic lineages maintained by continuous inhibition of extrinsic and intrinsic death pathways. , 2014, Immunity.

[91]  V. Bronte,et al.  Complexity and Challenges in Defining Myeloid-Derived Suppressor Cells , 2014, Cytometry. Part B, Clinical cytometry.

[92]  Juan Li,et al.  Myeloid-derived suppressor cells have a proinflammatory role in the pathogenesis of autoimmune arthritis , 2014, Annals of the rheumatic diseases.

[93]  L. Rydén,et al.  A high frequency of MDSCs in sepsis patients, with the granulocytic subtype dominating in gram‐positive cases , 2014, Journal of leukocyte biology.

[94]  Hyun-Jong Cho,et al.  Elevated endoplasmic reticulum stress reinforced immunosuppression in the tumor microenvironment via myeloid-derived suppressor cells , 2014, Oncotarget.

[95]  H. Jaspan,et al.  Myeloid Derived Suppressor Cells Are Present at High Frequency in Neonates and Suppress In Vitro T Cell Responses , 2014, PloS one.

[96]  Yan Cui,et al.  The stress-response sensor chop regulates the function and accumulation of myeloid-derived suppressor cells in tumors. , 2014, Immunity.

[97]  Xuetao Cao,et al.  The origin and function of tumor-associated macrophages , 2014, Cellular and Molecular Immunology.

[98]  C. Poets,et al.  Granulocytic myeloid derived suppressor cells expand in human pregnancy and modulate T‐cell responses , 2014, European journal of immunology.

[99]  T. Yen,et al.  IL-6-stimulated CD11b+CD14+HLA-DR− myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus , 2014, Oncotarget.

[100]  T. Glant,et al.  Identification of myeloid-derived suppressor cells in the synovial fluid of patients with rheumatoid arthritis: a pilot study , 2014, BMC Musculoskeletal Disorders.

[101]  H. Jaspan,et al.  The Role of Myeloid-Derived Suppressor Cells in Immune Ontogeny , 2014, Front. Immunol..

[102]  John M. Asara,et al.  Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function , 2014, Nature.

[103]  Jeffrey W Pollard,et al.  Tumor-associated macrophages: from mechanisms to therapy. , 2014, Immunity.

[104]  A. Wilk,et al.  Subpopulations of myeloid‐derived suppressor cells impair T cell responses through independent nitric oxide‐related pathways , 2014, International journal of cancer.

[105]  N. Hockstein,et al.  ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis. , 2014, The Journal of clinical investigation.

[106]  V. Bronte,et al.  Myeloid‐derived suppressor cell heterogeneity in human cancers , 2014, Annals of the New York Academy of Sciences.

[107]  Amber J. Giles,et al.  Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy , 2014, Science Translational Medicine.

[108]  M. De la Fuente,et al.  Chronic Inflammation and Cytokines in the Tumor Microenvironment , 2014, Journal of immunology research.

[109]  Viorel Simion,et al.  Subendothelial resistin enhances monocyte transmigration in a co-culture of human endothelial and smooth muscle cells by mechanisms involving fractalkine, MCP-1 and activation of TLR4 and Gi/o proteins signaling. , 2014, The international journal of biochemistry & cell biology.

[110]  T. Kielian,et al.  Myeloid-Derived Suppressor Cells Contribute to Staphylococcus aureus Orthopedic Biofilm Infection , 2014, The Journal of Immunology.

[111]  S. Spector,et al.  HIV type 1 gp120-induced expansion of myeloid derived suppressor cells is dependent on interleukin 6 and suppresses immunity. , 2014, The Journal of infectious diseases.

[112]  H. Yin,et al.  Polyunsaturated fatty acids promote the expansion of myeloid‐derived suppressor cells by activating the JAK/STAT3 pathway , 2013, European journal of immunology.

[113]  D. Gabrilovich,et al.  Myeloid-Derived Suppressor Cells in the Development of Lung Cancer , 2013, Cancer Immunology Research.

[114]  C. Poets,et al.  Neutrophilic myeloid‐derived suppressor cells in cord blood modulate innate and adaptive immune responses , 2013, Clinical and experimental immunology.

[115]  C. Bernstein,et al.  The role and potential therapeutic application of myeloid‐derived suppressor cells in TNBS‐induced colitis , 2013, Journal of leukocyte biology.

[116]  Kimberly R. Jordan,et al.  Myeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patients , 2013, Cancer Immunology, Immunotherapy.

[117]  A. Sevko,et al.  Tumor Microenvironment and Myeloid-Derived Suppressor Cells , 2013, Cancer Microenvironment.

[118]  R. Kiessling,et al.  Melanoma-educated CD14+ cells acquire a myeloid-derived suppressor cell phenotype through COX-2-dependent mechanisms. , 2013, Cancer research.

[119]  S. Kaneko,et al.  Increase in CD14+HLA-DR−/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis , 2013, Cancer Immunology, Immunotherapy.

[120]  B. Zhang,et al.  Increased CD14+HLA-DR-/low myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients , 2013, Cancer Immunology, Immunotherapy.

[121]  P. van Endert,et al.  Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells. , 2013, Immunity.

[122]  Je-in Youn,et al.  Abstract 1515: Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer. , 2013 .

[123]  Hong Wang,et al.  Increased circulating myeloid-derived suppressor cells correlated negatively with Th17 cells in patients with rheumatoid arthritis , 2013, Scandinavian journal of rheumatology.

[124]  Bin Zhang,et al.  Circulating and Tumor-Infiltrating Myeloid-Derived Suppressor Cells in Patients with Colorectal Carcinoma , 2013, PloS one.

[125]  M. Zucchetti,et al.  Role of macrophage targeting in the antitumor activity of trabectedin. , 2013, Cancer cell.

[126]  F. Hu,et al.  Clinical Significance and Functional Studies of Myeloid-Derived Suppressor Cells in Chronic Hepatitis C Patients , 2013, Journal of Clinical Immunology.

[127]  F. Végran,et al.  STAT3 activation , 2013, JAK-STAT.

[128]  R. Schoen,et al.  MUC1 Vaccine for Individuals with Advanced Adenoma of the Colon: A Cancer Immunoprevention Feasibility Study , 2012, Cancer Prevention Research.

[129]  F. Hu,et al.  Expansion of Monocytic Myeloid-Derived Suppressor Cells Dampens T Cell Function in HIV-1-Seropositive Individuals , 2012, Journal of Virology.

[130]  T. Glant,et al.  Suppression of dendritic cell maturation and T cell proliferation by synovial fluid myeloid cells from mice with autoimmune arthritis. , 2012, Arthritis and rheumatism.

[131]  P. J. Durant,et al.  Accumulation of Myeloid-Derived Suppressor Cells in the Lungs during Pneumocystis Pneumonia , 2012, Infection and Immunity.

[132]  Janet S. Lee,et al.  STAT1-Regulated Lung MDSC-like Cells Produce IL-10 and Efferocytose Apoptotic Neutrophils With Relevance In Resolution of Bacterial Pneumonia , 2012, Mucosal Immunology.

[133]  Ke Wang,et al.  Increased frequency and clinical significance of myeloid-derived suppressor cells in human colorectal carcinoma. , 2012, World journal of gastroenterology.

[134]  I. Hammami,et al.  Immunosuppressive activity enhances central carbon metabolism and bioenergetics in myeloid-derived suppressor cells in vitro models , 2012, BMC Cell Biology.

[135]  S. Lang,et al.  Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology , 2012, Cancer Immunology, Immunotherapy.

[136]  D. Gabrilovich,et al.  Coordinated regulation of myeloid cells by tumours , 2012, Nature Reviews Immunology.

[137]  V. Dixit,et al.  Signaling in innate immunity and inflammation. , 2012, Cold Spring Harbor perspectives in biology.

[138]  S. Singhal,et al.  Transcriptomic Analysis Comparing Tumor-Associated Neutrophils with Granulocytic Myeloid-Derived Suppressor Cells and Normal Neutrophils , 2012, PloS one.

[139]  S. Polyak,et al.  Myeloid suppressor cells induced by hepatitis C virus suppress T‐cell responses through the production of reactive oxygen species , 2012, Hepatology.

[140]  S. Biswas,et al.  Characterization of the nature of granulocytic myeloid‐derived suppressor cells in tumor‐bearing mice , 2012, Journal of leukocyte biology.

[141]  E. Pamer,et al.  Monocyte recruitment during infection and inflammation , 2011, Nature Reviews Immunology.

[142]  O. Fainaru,et al.  Immature myeloid cells accumulate in mouse placenta and promote angiogenesis. , 2011, American journal of obstetrics and gynecology.

[143]  S. Ostrand-Rosenberg,et al.  Gr-1+ CD11b+ Myeloid-derived Suppressor Cells Suppress Inflammation and Promote Insulin Sensitivity in Obesity* , 2011, The Journal of Biological Chemistry.

[144]  R. Ransohoff,et al.  Macrophages recruited via CCR2 produce insulin‐like growth factor‐1 to repair acute skeletal muscle injury , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[145]  C. Divino,et al.  Myeloid-Derived Suppressor Cells Prevent Type 1 Diabetes in Murine Models , 2010, The Journal of Immunology.

[146]  K. Nakai,et al.  The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection , 2010, Nature Immunology.

[147]  S. Kaneko,et al.  Involvement of CD11b+ GR-1low cells in autoimmune disorder in MRL-Faslpr mouse , 2010, Clinical and Experimental Nephrology.

[148]  M. Manns,et al.  CD49d Is a New Marker for Distinct Myeloid-Derived Suppressor Cell Subpopulations in Mice , 2010, The Journal of Immunology.

[149]  S. Bicciato,et al.  Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. , 2010, Immunity.

[150]  Steffen Jung,et al.  Development of Monocytes, Macrophages, and Dendritic Cells , 2010, Science.

[151]  E. Traggiai,et al.  Hierarchy of immunosuppressive strength among myeloid‐derived suppressor cell subsets is determined by GM‐CSF , 2009, European journal of immunology.

[152]  G. Cheng,et al.  Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. , 2009, Cancer cell.

[153]  J. Talmadge,et al.  Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells. , 2009, International immunopharmacology.

[154]  P. Allavena,et al.  Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. , 2009, Carcinogenesis.

[155]  Srinivas Nagaraj,et al.  Myeloid-derived suppressor cells as regulators of the immune system , 2009, Nature Reviews Immunology.

[156]  M. Munder,et al.  Monocyte dependent regulation of autoimmune inflammation. , 2009, Current molecular medicine.

[157]  L. Glimcher,et al.  The endoplasmic reticulum stress response in immunity and autoimmunity , 2008, Nature Reviews Immunology.

[158]  M. Zafarghandi,et al.  Concomitant carotid endarterectomy and coronary artery bypass grafting versus staged carotid stenting followed by coronary artery bypass grafting. , 2008, The Journal of cardiovascular surgery.

[159]  P. De Baetselier,et al.  Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. , 2008, Blood.

[160]  C. Dive,et al.  Obesity and cancer: Pathophysiological and biological mechanisms , 2008, Archives of physiology and biochemistry.

[161]  R. C. van der Veen,et al.  Mycobacteria‐induced Gr‐1+ subsets from distinct myeloid lineages have opposite effects on T cell expansion , 2007, Journal of leukocyte biology.

[162]  D. Rader.  Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus. , 2007, The American journal of medicine.

[163]  E. Ha,et al.  Reduced L-arginine level and decreased placental eNOS activity in preeclampsia. , 2006, Placenta.

[164]  S. Dubinett,et al.  Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma , 2005, The Journal of experimental medicine.

[165]  M. Belosevic,et al.  Regulation of myeloid development and function by colony stimulating factors. , 2004, Developmental and comparative immunology.

[166]  R. Jove,et al.  Hyperactivation of STAT3 Is Involved in Abnormal Differentiation of Dendritic Cells in Cancer , 2004, The Journal of Immunology.

[167]  D. Ramji,et al.  CCAAT/enhancer-binding proteins: structure, function and regulation. , 2002, The Biochemical journal.

[168]  P. Hwu,et al.  Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8+ T cell responses by dysregulating antigen-presenting cell maturation. , 1999, Journal of immunology.

[169]  B. Neyns,et al.  Combined VEGFR and CTLA-4 blockade increases the antigen-presenting function of intratumoral DCs and reduces the suppressive capacity of intratumoral MDSCs. , 2016, American journal of cancer research.

[170]  Y. Hiasa,et al.  Diminished immune response to vaccinations in obesity: role of myeloid-derived suppressor and other myeloid cells. , 2015, Obesity research & clinical practice.

[171]  O. Brawley,et al.  Obesity-driven inflammation and cancer risk: role of myeloid derived suppressor cells and alternately activated macrophages. , 2013, American journal of cancer research.

[172]  D. Gabrilovich,et al.  Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function. , 2011, Trends in immunology.

[173]  M. Nishimura,et al.  Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy , 2008, Cancer Immunology, Immunotherapy.

[174]  S. Ostrand-Rosenberg,et al.  The terminology issue for myeloid-derived suppressor cells. , 2007, Cancer research.